Vlaams Instituut voor Biotechnologie - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Vlaams Instituut voor Biotechnologie - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Vlaams Instituut voor Biotechnologie - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Vlaams Instituut voor Biotechnologie - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
31 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Vlaams Instituut voor Biotechnologie (VIB) is a life sciences research institute that offers agricultural, pharmaceutical and other industrial research programs. The institute offers research services in areas of bioinformatics, cardiovascular medicine, inflammation and immunity, neurosciences, proteomics, systems biology, among others. It offers research services which include sequencing and genotyping, assay development and compound screening, protein production, purification and analysis, nanobodies, bio imaging core, lab informatics, gateway services, and others. The institute also provides PhD program and a wide range of doctoral and postdoctoral courses in life sciences.

Vlaams Instituut voor Biotechnologie - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which ha

  
Source:
Document ID
GDPH141783D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Vlaams Instituut voor Biotechnologie, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Vlaams Instituut voor Biotechnologie, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Vlaams Instituut voor Biotechnologie, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Vlaams Instituut voor Biotechnologie, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Vlaams Instituut voor Biotechnologie, Medical Devices Deals, 2010 to YTD 201691
Vlaams Instituut voor Biotechnologie, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016102
Vlaams Instituut voor Biotechnologie, Pharmaceuticals &Healthcare, Deal Details1216
  Venture Financing121
    Confo Therapeutics Raises USD7.3 Million Financing122
    arGEN-X Secures US$37 Million In Series B Financing Round143
    Q-Biologicals Raises US$2.7 Million In Financing172
  Partnerships191
    BioPontis Alliance for Rare Diseases Enters into Co-Development Agreement with VIB191
    ThromboGenics Forms Joint Venture with VIB201
    VIB Enters Into Co-Development Agreement With Janssen R&D211
    VIB Enters Into Co-Development Agreement With Cellectis221
  Licensing Agreements231
    AstraZeneca Enters Into Licensing Agreement with VIB and CD3232
  Acquisition251
    Intrexon to Acquire ActoGeniX for USD60 Million253
Vlaams Instituut voor Biotechnologie - Key Competitors281
Key Employees291
Locations And Subsidiaries301
  Head Office301
Appendix311
  Methodology311
  About GlobalData311
  Contact Us311
  Disclaimer311

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Vlaams Instituut voor Biotechnologie - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Vlaams-Instituut-voor-Biotechnologie-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13648>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Vlaams Instituut voor Biotechnologie - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Vlaams-Instituut-voor-Biotechnologie-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13648>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research